Crinetics Pharmaceuticals CFO Marc Wilson Resigns
Company Announcements

Crinetics Pharmaceuticals CFO Marc Wilson Resigns

An update from Crinetics Pharmaceuticals (CRNX) is now available.

Marc Wilson has announced his resignation as the Chief Financial Officer of the Company, effective once a successor is found and transitioned into the role. The company is actively searching for a new CFO. Wilson’s decision to leave is due to personal reasons and not due to any disputes or disagreements with the company’s operations or practices.

For detailed information about CRNX stock, go to TipRanks’ Stock Analysis page.

Related Articles
GlobeNewswireCrinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireCrinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
GlobeNewswireCrinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App